TITLE

ANTIGLAUCOMA, ADRENERGIC AGONISTS

AUTHOR(S)
GRIFFITH, H. WINTER
PUB. DATE
January 2010
SOURCE
Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p92
SOURCE TYPE
Encyclopedia
DOC. TYPE
Article
ABSTRACT
The article presents information on adrenergic agonists antiglaucoma, a drug developed to treat open-angle glaucoma, secondary glaucoma and ocular hypertension, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.
ACCESSION #
44862644

 

Related Articles

  • ANTIGLAUCOMA, CARBONIC ANHYDRASE INHIBITORS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p98 

    The article presents information on carbonic anhydrase inhibitor, an antiglaucoma drug, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • ANTIGLAUCOMA, CARBONIC ANHYDRASE INHIBITORS. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p98 

    The article presents information on carbonic anhydrase inhibitors, a drug developed to treat open-angle glaucoma and ocular hypertension, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • travoprost.  // Royal Society of Medicine: Medicines;2002, p543 

    This article presents information on the travoprost which is a synthetic prostaglandin analogue, that has been introduced as a novel glaucoma treatment to reduce intraocular pressure in open-angle glaucoma and ocular hypertension in patients for whom other drugs are not suitable. Administration...

  • Brimonidine/timolol.  // Reactions Weekly;2/1/2014, Issue 1486, p10 

    The article presents two case studies of patients diagnosed with granulomatous inflammations of the eye developed while receiving brimonidine/timolol for their open angle glaucoma.

  • Bimatoprost and Bimatoprost/Timolol Fixed Combination in Patients with Open-Angle Glaucoma and Ocular Hypertension. Katsanos, Andreas; Dastiridou, Anna I.; Fanariotis, Michael; Kotoula, Maria; Tsironi, Evangelia E. // Journal of Ocular Pharmacology & Therapeutics;Feb2011, Vol. 27 Issue 1, p67 

    Purpose: To investigate the intraocular pressure (IOP) lowering effect of bimatoprost (BIM) 0.03% and the potential additional effect of the BIM 0.03%/timolol 0.5% fixed combination (BTFC) in eyes with ocular hypertension, primary open-angle glaucoma, or exfoliation glaucoma. Methods: Following...

  • Latanoprost for open-angle glaucoma.  // American Family Physician;1/1/1997, Vol. 55 Issue 1, p355 

    Reports on the approval given by the United States Food and Drug Administration for a treatment for open-angle glaucoma, called Latanoprost solution (Xalatan). Types of patients the treatment should be administered to; Side effects of the treatment; What the treatment is related to.

  • Primer Açık Açılı Glokomda Topikal Sabit Kombinasyon Ä°laç Tedavilerinin Tolerabilitelerinin Ä°ncelenmesi. Özer, Murat Atabey; Yıldırım, Cem // Journal of Turgut Ozal Medical Center;2014, Vol. 21 Issue 1, p27 

    Aim: The aim of this study was to investigate the ocular tolerability of topical drug treatments of brimonide tartrate-timolol maleate, dorzolamid hydrochloride-timolol maleate and latanoprost-timolol maleate in patients with primary open angle glaucoma. Material and Methods: A total of 58...

  • Decreased keratocyte density and central corneal thickness in primary open-angle glaucoma patients undergoing treatment with topical prostaglandin analogues. Kocabeyoglu, Sibel; Mocan, Mehmet C.; Irkec, Murat // Indian Journal of Ophthalmology;Jan2015, Vol. 63 Issue 1, p15 

    Purpose: To evaluate whether prostaglandin (PG) analogue use is associated with alterations in keratocyte density and central corneal thickness (CCT) in subjects with primary open-angle glaucoma (POAG). Materials and Methods: Thirty-five POAG patients treated with PG analogues for >2 years and...

  • ANTIGLAUCOMA, ADRENERGIC AGONISTS.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2009, p94 

    The article presents information on adrenergic agonists, an antiglaucoma drug, including dosage, usage, adverse reactions, side effects, precautions, and possible interaction with other drugs.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics